Text to be removed highlighted in red.
1 Use of Cannabis for Therapeutic Purposes; Definitions; Cannabis. Amend RSA 126-X:1, III to read as follows:
III. "Cannabis" means all parts of any plant of the Cannabis genus of plants, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, salt, derivative, mixture, or preparation of such plant, its seeds, or resin. Such term shall not include the mature stalks of such plants, fiber produced from such stalks, oil, or cake made from the seeds of such plants, any other compound, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seeds of such plants which are incapable of germination. In this chapter, cannabis shall not include hemp grown, processed, marketed, or sold under RSA 439-A .
2 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:
XIX.(a) An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, CBD and other hemp-derived non-intoxicating cannabinoids not produced by an alternative treatment center in New Hampshire. All such non-intoxicating cannabinoids, and all cannabis concentrate and cannabis infused products manufactured from such non-intoxicating cannabinoids, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.
(b) An alternative treatment center shall not use products that are derived from hemp which contain natural or synthetic tetrahydrocannabinol (THC) greater than 0.3 percent on a dry weight basis, which appear in any formulation, including delta-8 THC, delta-9 THC, or any other THC isomer variant.
3 Effective Date. This act shall take effect 60 days after its passage.
Text to be added highlighted in green.
1 Use of Cannabis for Therapeutic Purposes; Definitions; Cannabis. Amend RSA 126-X:1, III to read as follows:
III. "Cannabis" means all parts of any plant of the Cannabis genus of plants, whether growing or not; the resin extracted from any part of such plant; and every compound, salt, derivative, mixture, or preparation of such plant, or its resin. Such term shall not include the mature stalks of such plants, fiber produced from such stalks, oil, or cake made from the seeds of such plants, any other compound, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil , or cake. In this chapter, cannabis shall not include hemp grown, processed, marketed, or sold under RSA 439-A , except as provided inRSA 126-X:8, XIX .
2 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:
XIX.(a) An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, CBD and other hemp-derived non-intoxicating cannabinoids not produced by an alternative treatment center in New Hampshire. All such non-intoxicating cannabinoids, and all cannabis concentrate and cannabis infused products manufactured from such non-intoxicating cannabinoids, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.
(b) An alternative treatment center shall not use products that are derived from hemp which contain natural or synthetic tetrahydrocannabinol (THC) greater than 0.3 percent on a dry weight basis, which appear in any formulation, including delta-8 THC, delta-9 THC, or any other THC isomer variant.
3 Effective Date. This act shall take effect 60 days after its passage.